Status:

COMPLETED

Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities

Lead Sponsor:

Georgetown University

Collaborating Sponsors:

Medstar Health Research Institute

Howard University

Conditions:

Stroke

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to increase treatment of acute stroke with tissue plasminogen activator (tPA) across the District of Columbia. This study, however, will not evaluate tPA as an interventio...

Detailed Description

There are a number of well-known barriers to receiving tissue plasminogen activator (tPA) including transit time to hospital, paramedic and provider training, tPA standing orders, and provider guideli...

Eligibility Criteria

Inclusion

  • diagnosis of acute ischemic stroke
  • over the age of 18

Exclusion

  • \-

Key Trial Info

Start Date :

February 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2013

Estimated Enrollment :

2005 Patients enrolled

Trial Details

Trial ID

NCT00724555

Start Date

February 1 2008

End Date

January 1 2013

Last Update

January 31 2014

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Georgetown University, ASPIRE Coordinating Center

Washington D.C., District of Columbia, United States, 20007

2

Washington Hospital Center

Washington D.C., District of Columbia, United States, 20010

3

Sibley Memorial Hospital

Washington D.C., District of Columbia, United States, 20016

4

Providence Hospital

Washington D.C., District of Columbia, United States, 20017